Nanotechnology Now - Press Release: Tech company NANOBIOTIX announces late-stage registration trial and global development plan for 2020

Date 8th, Jan 2020
Source Nanotechnology Now - Nanotechnology Websites

DESCRIPTION

After establishing proof-of-concept and first market approval for NBTXR3 in soft tissue sarcoma of the extremities and trunk wall, Nanobiotix is now focused on developing this product in the United S...